CD8A and nonpapillary renal cell carcinoma: To assess the potential immune differences between healthy people (n = 350) and ccRCC patients (n = 274), we collected peripheral blood and tested CD8+ T cells (CD3+CD4−CD8+) proportion of CD3+ cells.